Concepedia

Kristine S. Klos

KS

14

Publications

3.4K

Citations

14

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Wisconsin–Madison

Fudan University Shanghai Cancer Center

Kristine S. Klos is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2001–2021

14

Publications

14

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou et al. · Cancer Cell · 2004 · 1.8K citations · Full text

, , +12

Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers

Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne et al. · Clinical Cancer Research · 2004 · 312 citations · Full text

ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells

Kristine S. Klos, Shannon L. Wyszomierski, Menghong Sun et al. · Cancer Research · 2006 · 199 citations · Full text

Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells

Jun Yao, Shunbin Xiong, Kristine S. Klos et al. · Oncogene · 2001 · 169 citations

, , +9

The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage

Nisha M. Badders, Shruti Goel, Rod J. Clark et al. · PLoS ONE · 2009 · 129 citations · Full text

Rows per page

1–5 of 14